These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 17525967

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Stent thrombosis with drug-eluting stents: a re-examination of the evidence.
    Kedia G, Lee MS.
    Catheter Cardiovasc Interv; 2007 May 01; 69(6):782-9. PubMed ID: 17394249
    [Abstract] [Full Text] [Related]

  • 8. Off-label use of stents: bare-metal versus drug-eluting stents.
    Girod JP, Mulukutla SR, Marroquin OC.
    Expert Rev Cardiovasc Ther; 2008 Sep 01; 6(8):1095-106. PubMed ID: 18793112
    [Abstract] [Full Text] [Related]

  • 9. Emergency percutaneous coronary intervention (PCI) for the care of patients with ST-elevation myocardial infarction (STEMI).
    Morrison DA, Berman M, El-Amin O, McLaughlin RT, Bates ER.
    Minerva Cardioangiol; 2007 Oct 01; 55(5):593-623. PubMed ID: 17912165
    [Abstract] [Full Text] [Related]

  • 10. [Stent thrombosis in the era of drug-eluting stents].
    Wöhrle J.
    Herz; 2007 Aug 01; 32(5):411-8. PubMed ID: 17687531
    [Abstract] [Full Text] [Related]

  • 11. Impact of "off-label" utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention.
    Roy P, Buch AN, Javaid A, Okabe T, Raya V, Pinto Slottow TL, Steinberg DH, Smith K, Xue Z, Gevorkian N, Satler LF, Kent KM, Suddath WO, Pichard AD, Lindsay J, Waksman R.
    Am J Cardiol; 2008 Feb 01; 101(3):293-9. PubMed ID: 18237587
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials.
    Piscione F, Piccolo R, Cassese S, Galasso G, Chiariello M.
    Catheter Cardiovasc Interv; 2009 Aug 01; 74(2):323-32. PubMed ID: 19360858
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
    Tanzilli G, Greco C, Pelliccia F, Pasceri V, Barillà F, Paravati V, Pannitteri G, Gaudio C, Mangieri E.
    Am J Cardiol; 2009 Nov 15; 104(10):1357-61. PubMed ID: 19892050
    [Abstract] [Full Text] [Related]

  • 20. Comparison of long-term outcomes of bare metal or drug-eluting stent implantation in standard versus off-label coronary narrowings.
    Harjai KJ, Orshaw P, Boura J, Sporn D.
    Am J Cardiol; 2009 Jun 01; 103(11):1537-45. PubMed ID: 19463512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.